NuMedii Company

NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
Technology: Drug Repurposing
Industry: Drug Discovery
Headquarters: USA
Founded Date: 2008

Visit Website
busdev@numedii.com
twitter.com/NuMedii
Register and Claim Ownership